Kyung Jin Chung1,2, Jae Heon Kim1, Gyeong Eun Min1, Hyoung Keun Park1, Shufeng Li1,3, Francesco Del Giudice4, Deok Hyun Han1,5, Benjamin I Chung1. 1. 1 Department of Urology, Stanford University Medical Center, Stanford, California. 2. 2 Department of Urology, Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea. 3. 3 Department of Urology and Dermatology, Stanford University Medical Center, Stanford, California. 4. 4 Department of Urology, Sapienza Rome University, Policlinico Umberto I, Rome, Italy. 5. 5 Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Abstract
INTRODUCTION: Changes in the surgical treatment of nephrolithiasis, owing to recent technical advances and innovations, have made treatments more effective and less invasive. In this retrospective, observational cohort study, we identified the changing trends in the treatment of nephrolithiasis. MATERIALS AND METHODS: We included patients with newly diagnosed nephrolithiasis who received any treatment in the United States, including extracorporeal shockwave lithotripsy (SWL), retrograde intrarenal surgery (RIRS), percutaneous nephrolithotomy (PCNL), and open surgery, from January 2007 to December 2014. Demographic factors, such as age, sex, region, surgical treatment type, and cost data, were analyzed. RESULTS: The median age of patients at treatment was 52 years, and the ratio of men and women was similar. There were definite changes in the trends of all treatment modalities (p < 0.01). Both the number and percentage tended to increase for RIRS, whereas for SWL, the number increased, but the percentage showed a steady decrease. In PCNL, both number and percentage increased to a minor degree. The overall cost of nephrolithiasis treatments during the study period nearly doubled (from $30,998,726 to $57,310,956). The number of treatments and average cost per treatment increased annually for each treatment modality. RIRS was the least expensive; the other procedures in decreasing order of their mean costs were as follows: SWL, PCNL, and open surgery. CONCLUSIONS: There was a gradual but constant change in treatment trends of nephrolithiasis, with an increasing trend for RIRS and a decreasing trend for SWL. Although PCNL has relatively invasive characteristics, it is still in steady demand.
INTRODUCTION: Changes in the surgical treatment of nephrolithiasis, owing to recent technical advances and innovations, have made treatments more effective and less invasive. In this retrospective, observational cohort study, we identified the changing trends in the treatment of nephrolithiasis. MATERIALS AND METHODS: We included patients with newly diagnosed nephrolithiasis who received any treatment in the United States, including extracorporeal shockwave lithotripsy (SWL), retrograde intrarenal surgery (RIRS), percutaneous nephrolithotomy (PCNL), and open surgery, from January 2007 to December 2014. Demographic factors, such as age, sex, region, surgical treatment type, and cost data, were analyzed. RESULTS: The median age of patients at treatment was 52 years, and the ratio of men and women was similar. There were definite changes in the trends of all treatment modalities (p < 0.01). Both the number and percentage tended to increase for RIRS, whereas for SWL, the number increased, but the percentage showed a steady decrease. In PCNL, both number and percentage increased to a minor degree. The overall cost of nephrolithiasis treatments during the study period nearly doubled (from $30,998,726 to $57,310,956). The number of treatments and average cost per treatment increased annually for each treatment modality. RIRS was the least expensive; the other procedures in decreasing order of their mean costs were as follows: SWL, PCNL, and open surgery. CONCLUSIONS: There was a gradual but constant change in treatment trends of nephrolithiasis, with an increasing trend for RIRS and a decreasing trend for SWL. Although PCNL has relatively invasive characteristics, it is still in steady demand.
Entities:
Keywords:
cost and cost analysis; lithotripsy; nephrolithiasis; operative; therapeutics
Authors: Francesco Del Giudice; Jianlin Huang; Shufeng Li; Simon Sorensen; Ekene Enemchukwu; Martina Maggi; Stefano Salciccia; Matteo Ferro; Felice Crocetto; Savio Domenico Pandolfo; Riccardo Autorino; Wojciech Krajewski; Simone Crivellaro; Giovanni E Cacciamani; Eugenio Bologna; Vincenzo Asero; Carlo Scornajenghi; Marco Moschini; David D'Andrea; David R Brown; Benjamin I Chung Journal: Prostate Cancer Prostatic Dis Date: 2022-06-21 Impact factor: 5.554
Authors: Scott R Hawken; Spencer C Hiller; Stephanie Daignault-Newton; Khurshid R Ghani; John M Hollingsworth; Bronson Conrado; Conrad Maitland; David L Wenzler; John K Ludlow; Sapan N Ambani; Chad M Brummett; Casey A Dauw Journal: Urology Date: 2021-09-01 Impact factor: 2.649
Authors: Antonio Corrêa Lopes; Vinícius Dall'Aqua; Raphael V Carrera; Wilson R Molina; Sidney Glina Journal: Int Braz J Urol Date: 2021 Mar-Apr Impact factor: 1.541